Emergent BioSolutions (EBS) EV to CFO (2011 - 2026)
Emergent BioSolutions' (EBS) EV to CFO stood at 0.81 in Q3 2026, down 95.2% from 16.87 a year earlier and down 72.6% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) EV to CFO (2011 - 2026) Analysis & Trends
On a TTM basis, Emergent BioSolutions' EV to CFO came in at -1.71 as of Sep 30, 2026; for FY2025, it was 2.57, down 64.0% from FY2024.
- Across earlier years, EV to CFO came in at 7.15 in FY2024 and 5.17 in FY2021 (-33.0%).
- The Q3 2026 figure is the lowest quarterly EV to CFO since Q2 2025.
- On a year-over-year basis, EV to CFO rose in three of the last six quarters, with growth averaging 207.8%.
- Peak year-over-year performance for EV to CFO in the last five years was growth of 854.1% in Q3 2025, against a decline of 95.2% in Q3 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at 2.97 (Q2 2026), 1.82 (Q1 2026) and 2.57 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Emergent BioSolutions | 310.37 Mn | -370.73 Mn | 29.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 0.81 |
| Jun 30, 2026 | 2.97 |
| Mar 31, 2026 | 1.82 |
| Dec 31, 2025 | 2.57 |
| Sep 30, 2025 | 16.87 |
| Jun 30, 2025 | 0.45 |
| Mar 31, 2025 | 1.05 |
| Dec 31, 2024 | 7.15 |
| Sep 30, 2024 | 1.77 |
| Jun 30, 2024 | 3.78 |
| Sep 30, 2022 | 4.01 |
| Jun 30, 2022 | 4.08 |
| Mar 31, 2022 | 5.88 |
| Dec 31, 2021 | 5.17 |
| Sep 30, 2021 | 9.60 |
| Jun 30, 2021 | 8.99 |
| Mar 31, 2021 | 9.15 |
| Dec 31, 2020 | 7.70 |
| Sep 30, 2020 | 12.26 |
| Jun 30, 2020 | 12.85 |
API Access
Emergent BioSolutions EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();